机构:[1]Department of Thyroid Surgery, Clinical Research Center for Thyroid Diseases of Yunnan Province, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, China.昆明医科大学附属第一医院[2]Department of Management of Chronic Non-communicable Diseases, Yunnan Center for Disease Control and Prevention, Kunming 650034, China.
81760142/National Natural Science Foundation of China,
2X2019-03-03/Construction Project of Clinical Research Centre of General Surgical Disease in Yunnan Province,
RLCRC20210412/"Ten Thousand People Plan" of Yunnan Province-Medical Experts Project
第一作者机构:[1]Department of Thyroid Surgery, Clinical Research Center for Thyroid Diseases of Yunnan Province, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, China.
共同第一作者:
推荐引用方式(GB/T 7714):
Wen Liu,Xuejing Yan,Ruochuan Cheng.The active surveillance management approach for patients with low risk papillary thyroid microcarcinomas: is China ready?[J].CANCER BIOLOGY & MEDICINE.2022,19(5):619-634.doi:10.20892/j.issn.2095-3941.2021.0058.
APA:
Wen Liu,Xuejing Yan&Ruochuan Cheng.(2022).The active surveillance management approach for patients with low risk papillary thyroid microcarcinomas: is China ready?.CANCER BIOLOGY & MEDICINE,19,(5)
MLA:
Wen Liu,et al."The active surveillance management approach for patients with low risk papillary thyroid microcarcinomas: is China ready?".CANCER BIOLOGY & MEDICINE 19..5(2022):619-634